Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Journal of Pharmaceutical Sciences
|
July 29, 2019
Impact of Inadequate Methods and Data Analysis on Reproducibility
Steve Elliott
Journal of Pharmaceutical Sciences
|
February 18, 2016
Bad Science: Cause and Consequence
Steve Elliott
Cancer Treatment and Research
|
November 6, 2010
Erythropoiesis-stimulating agents
Steve Elliott
Bioanalysis
|
July 27, 2012
Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
Steve Elliott, Barbara Leishman
Journal of Pharmaceutical Sciences
|
June 17, 2005
Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins
Angus M Sinclair, Steve Elliott
Biologics : Targets & Therapy
|
August 1, 2012
The effect of erythropoietin on normal and neoplastic cells
Steve Elliott, Angus M Sinclair
BMC Nephrology
|
January 13, 2017
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Steve Elliott, Dianne Tomita, Zoltan Endre
Clinical Kidney Journal
|
October 2, 2023
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
Francesco Locatelli, Lucia Del Vecchio, Steve Elliott
Experimental Hematology
|
October 17, 2008
Erythropoietins: a common mechanism of action
Steve Elliott, Elizabeth Pham, Iain C Macdougall
Health Care for Women International
|
April 9, 2011
Using the dimensions of health to assess motivation among running moms
Kerry Whipple, Sue Combs, Deborah Dowd, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Journal of Pharmaceutical Sciences
|
July 29, 2019
Impact of Inadequate Methods and Data Analysis on Reproducibility
Steve Elliott
Journal of Pharmaceutical Sciences
|
February 18, 2016
Bad Science: Cause and Consequence
Steve Elliott
Cancer Treatment and Research
|
November 6, 2010
Erythropoiesis-stimulating agents
Steve Elliott
Bioanalysis
|
July 27, 2012
Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
Steve Elliott, Barbara Leishman
Journal of Pharmaceutical Sciences
|
June 17, 2005
Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins
Angus M Sinclair, Steve Elliott
Biologics : Targets & Therapy
|
August 1, 2012
The effect of erythropoietin on normal and neoplastic cells
Steve Elliott, Angus M Sinclair
BMC Nephrology
|
January 13, 2017
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Steve Elliott, Dianne Tomita, Zoltan Endre
Clinical Kidney Journal
|
October 2, 2023
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
Francesco Locatelli, Lucia Del Vecchio, Steve Elliott
Experimental Hematology
|
October 17, 2008
Erythropoietins: a common mechanism of action
Steve Elliott, Elizabeth Pham, Iain C Macdougall
Health Care for Women International
|
April 9, 2011
Using the dimensions of health to assess motivation among running moms
Kerry Whipple, Sue Combs, Deborah Dowd, et al.
Page
of 4